Contact:
Thomas Monroe, Glanbia Nutritionals (NA), Inc
Carlsbad, CA 92008 760-438-0089
tmonroe@glanbia.com

FOR IMMEDIATE RELEASE

Ganeden Biotech Names Glanbia Nutritionals as Primary North American Distributor of GanedenBC^30® Probiotic
New partnership will expand Ganeden’s reach and Glanbia’s nutritional ingredient portfolio

CLEVELAND (October 12, 2010) – Ganeden Biotech Inc., maker of the patented probiotic strain GanedenBC^30®, today announced the appointment of Glanbia Nutritionals, global ingredient and micronutrient premix company, as their primary North American distributor of GanedenBC^30®.

Ganeden Biotech, which already has a strong footing in the ingredient industry with over 50 national and international foods, beverages and nutritional supplements containing GanedenBC^30® as an added ingredient, will be able to capitalize on Glanbia’s distribution expertise and vast warehouse network located throughout North America.

“To become a partner of Glanbia Nutritionals is an incredible opportunity,” said Andrew Lefkowitz, Ganeden Biotech President and CEO. “Glanbia has a vast distribution base throughout the US and we are simply thrilled that GanedenBC30® is going to be readily accessible to companies looking to use our probiotic to enhance their products”

Probiotics are “good bacteria” that have been shown to improve digestive health and support immunity. In order for probiotics to be effective they must survive manufacturing processes, shelf life, stomach acids and intestinal bile to arrive in the intestinal tract where they can have the greatest digestion health benefit.

Unlike many currently available probiotic ingredients, GanedenBC^30® is able to survive harsh manufacturing processes, including baking, freezing, boiling and high pressure. This is due to the naturally-occurring layer of organic material that protects the genetic core of the bacteria, allowing GanedenBC^30® to survive.

“Ganeden’s probiotics are a great fit with our product portfolio because they meet our strict stability requirements for food and beverage applications,” said Richard Hazel, CEO of Glanbia Nutritionals (NA), Inc. “We are pleased with the addition of GanedenBC^30®, which now allows us to work with applications that weren’t previously thought possible. The new distribution partnership will also benefit Glanbia Nutritionals by furthering our aim of expanding nationwide leadership in the ingredient industry.”

About Ganeden Biotech

Founded in 1997, Ganeden Biotech, Inc. is based in Cleveland, Ohio, and is the largest seller of over-the-counter probiotics in the U.S. through its Digestive Advantage® and Sustenex® brands. They also license their patented probiotic bacteria, GanedenBC^30®, for use in commercial food and beverage applications, nutraceuticals and in animal health industries. GanedenBC^30® is self-affirmed GRAS (Generally Recognized as Safe) by an independent panel of experts assembled to assess its safety in use as a food ingredient. For more information about licensing opportunities visit www.ganedenlabs.com.

About Glanbia Nutritionals

Glanbia Nutritionals is a division of Glanbia plc, an international cheese and nutritional ingredients group, headquartered in Kilkenny, Ireland. The Group has 4,300 employees worldwide, with operations in Ireland, the UK, Germany, USA, Canada and China, as well as strategic international joint ventures in the UK, USA and Nigeria. Glanbia is listed on both the Dublin and London Stock Exchange.

Glanbia is the largest dairy processor in Ireland and a global supplier of nutritional ingredients, functional ingredients and customized premix solutions. Glanbia Nutritionals is on the forefront in the exploration of science and the dynamics that drive the growing nutrition industry. For more information visit www.glanbianutritionals.com. or contact Thomas Monroe, Marketing, 760.438.0089, tmonroe@glanbia.com.

# # #